B cell αv integrins regulate development of autoimmunity in murine lupus models

Abstract

Abstract B cell activation by self-antigen and signaling through Toll-like receptors (TLR) such as TLR7 and TLR9 has been implicated in the development of autoimmunity. We have recently identified a mechanism by which αvβ3 integrin limit excessive B cell responses to antigens containing TLR ligands, including self-antigens. We have previously reported that mice in which αv integrins are selectively deleted from B cells develop increased levels of autoantibodies to RNA and double stranded DNA. Based on these findings, we hypothesized that deletion of αv integrins would accelerate TLR dependent autoimmunity. To study this further, we crossed mice lacking αv integrins on B cells (αv-CD19 mice) with mice expressing increased levels of TLR7 (TLR7.1tg mice) that develop Lupus-like autoimmunity. We find that the resulting αv-CD19 TLR7tg mice had increased spleen weight in comparison with age-matched TLR7tg littermates. αv-CD19 TLR7tg mice also had increased number of IgG2c+ plasma cells and increased autoantibodies to RNA, all indicative of enhanced B Cell activation and development of autoimmunity. In addition, deletion of αv integrin on B Cells in this model leads to enhanced activation of T Cells. Currently, we are investigating the role of αv integrins on B Cell subpopulations in driving T Cell activation and antigen presentation in this model of autoimmunity. B Cells contribute to autoimmunity by activating T Cells in addition to producing autoantibodies and cytokines. These studies allow us to understand how altered B Cell TLR signaling can lead to enhanced immune activation in autoimmunity and highlight the importance of αv integrins in regulating this process.